Daniel R Kuritzkes
Overview
Explore the profile of Daniel R Kuritzkes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
309
Citations
10141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Inzaule S, Jordan M, Fokam J, Hamers R, Paredes R, Crowell T, et al.
AIDS
. 2025 Mar;
PMID: 40053490
An increasing number of people living with HIV (PLHIV) are failing treatment without HIV drug resistance in the drug target region. While sub-optimal adherence is likely the cause of treatment...
2.
Song Y, Park H, Thirumalaraju P, Kovilakath N, Hardie J, Bigdeli A, et al.
ACS Nano
. 2025 Feb;
19(9):8646-8660.
PMID: 40017424
Digital nucleic acid assays, known for their high sensitivity and specificity, typically rely on fluorescent readouts and expensive and complex nanowell manufacturing, which constrain their broader use in point-of-care (POC)...
3.
Pickering R, Asundi A, Olson A, Soden K, Kuritzkes D, Lin N
Antivir Ther
. 2025 Feb;
30(1):13596535251314571.
PMID: 39953931
Background: Integrase strand transfer inhibitors (INSTIs) have been associated with excess weight gain in people living with HIV compared to other antiretroviral agents. The mechanisms that underlie these effects are...
4.
Apea V, Titanji B, Dakin F, Hayes R, Smuk M, Kawu H, et al.
PLOS Glob Public Health
. 2025 Feb;
5(2):e0003704.
PMID: 39951482
In May 2022, the most widespread outbreak of sustained transmission of mpox outside of countries historically affected countries in Western and Central Africa occurred. We aimed to examine the personal...
5.
Kuritzkes D
Clin Infect Dis
. 2024 Oct;
79(Supplement_4):S127-S130.
PMID: 39445631
No abstract available.
6.
Henrich T, Bosch R, Godfrey C, Mar H, Nair A, Keefer M, et al.
Cell Rep Med
. 2024 Sep;
5(10):101745.
PMID: 39321793
Key HIV cure strategies involve reversing immune dysfunction and limiting the proliferation of infected T cells. We evaluate the safety of sirolimus, a mammalian target of rapamycin (mTOR) inhibitor, in...
7.
Fridman I, Eyal N, Scherr K, Currier J, Freedberg K, Halpern S, et al.
AIDS Res Ther
. 2024 Aug;
21(1):51.
PMID: 39107832
Background: In the US, 1.2 million people live with HIV (PWH). Despite having near-normal life expectancies due to antiretroviral therapy (ART), many PWH seek an HIV cure, even if it...
8.
Sakoi-Mosetlhi M, Ajibola G, Haghighat R, Batlang O, Maswabi K, Pretorius-Holme M, et al.
PLoS One
. 2024 Jul;
19(7):e0307065.
PMID: 38985747
[This corrects the article DOI: 10.1371/journal.pone.0299942.].
9.
10.
Doganay M, Roman E, Hujer A, Bonomo R, Deeks S, Kuritzkes D, et al.
Adv Mater
. 2024 Apr;
36(28):e2311634.
PMID: 38657970
Nucleic acid amplification, the bedrock of biotechnology and molecular diagnostics, surges in applications-especially isothermal approaches-heightening the demand for advanced and precisely engineered methods. Here, a novel approach for amplifying DNA...